Daniel D Maeng

Summary

Affiliation: Geisinger Medical Center
Country: USA

Publications

  1. doi request reprint Reduced Acute Inpatient Care Was Largest Savings Component Of Geisinger Health System's Patient-Centered Medical Home
    Daniel D Maeng
    Daniel D Maeng is a research investigator for the Center for Health Research at Geisinger Health System, in Danville, Pennsylvania
    Health Aff (Millwood) 34:636-44. 2015
  2. doi request reprint Improving patient experience by transforming primary care: evidence from Geisinger's patient-centered medical homes
    Daniel D Maeng
    Geisinger Health System, Danville, PA, USA
    Popul Health Manag 16:157-63. 2013
  3. pmc Comparing patient outcomes across payer types: implications for using hospital discharge records to assess quality
    Daniel D Maeng
    Geisinger Center for Health Research, 100 N Academy Avenue M C 44 00, Danville, PA 17822, USA
    Health Serv Res 46:1720-40. 2011
  4. pmc Care coordination for the chronically ill: understanding the patient's perspective
    Daniel D Maeng
    Geisinger Center for Health Research, 100 N Academy Ave M C 44 00 Danville, PA 17822, USA
    Health Serv Res 47:1960-79. 2012
  5. doi request reprint Can a patient-centered medical home lead to better patient outcomes? The quality implications of Geisinger's ProvenHealth Navigator
    Daniel D Maeng
    Geisinger Health System, Danville, PA 17822, USA
    Am J Med Qual 27:210-6. 2012
  6. ncbi request reprint Reducing long-term cost by transforming primary care: evidence from Geisinger's medical home model
    Daniel D Maeng
    Geisinger Center for Health Research, Danville, PA 17822, USA
    Am J Manag Care 18:149-55. 2012
  7. doi request reprint Can health insurance improve employee health outcome and reduce cost? An evaluation of Geisinger's employee health and wellness program
    Daniel D Maeng
    Geisinger Health System Drs Maeng and Steinhubl and Mr Pitcavage and Geisinger Health Plan Ms Tomcavage, Danville, PA
    J Occup Environ Med 55:1271-5. 2013
  8. pmc Cost-effectiveness of IL28Β genotype-guided protease inhibitor triple therapy versus standard of care treatment in patients with hepatitis C genotypes 2 or 3 infection
    Jonathan A Bock
    Weis Center for Research, Geisinger Medical Center, Danville, PA, USA
    Public Health Genomics 17:306-19. 2014

Detail Information

Publications8

  1. doi request reprint Reduced Acute Inpatient Care Was Largest Savings Component Of Geisinger Health System's Patient-Centered Medical Home
    Daniel D Maeng
    Daniel D Maeng is a research investigator for the Center for Health Research at Geisinger Health System, in Danville, Pennsylvania
    Health Aff (Millwood) 34:636-44. 2015
    ..The results of this study suggest that patient-centered medical homes can lead to sustainable, long-term improvements in patient health outcomes and the cost of care. ..
  2. doi request reprint Improving patient experience by transforming primary care: evidence from Geisinger's patient-centered medical homes
    Daniel D Maeng
    Geisinger Health System, Danville, PA, USA
    Popul Health Manag 16:157-63. 2013
    ..These findings are consistent with the expectation that transformation of primary care into PCMH can lead to improved patient experience of care...
  3. pmc Comparing patient outcomes across payer types: implications for using hospital discharge records to assess quality
    Daniel D Maeng
    Geisinger Center for Health Research, 100 N Academy Avenue M C 44 00, Danville, PA 17822, USA
    Health Serv Res 46:1720-40. 2011
    ..To explain observed differences in patient outcomes across payer types using hospital discharge records. Specifically, we address two mechanisms: hospital-payer matching versus unobserved patient heterogeneity...
  4. pmc Care coordination for the chronically ill: understanding the patient's perspective
    Daniel D Maeng
    Geisinger Center for Health Research, 100 N Academy Ave M C 44 00 Danville, PA 17822, USA
    Health Serv Res 47:1960-79. 2012
    ..To identify factors associated with perception of care coordination problems among chronically ill patients...
  5. doi request reprint Can a patient-centered medical home lead to better patient outcomes? The quality implications of Geisinger's ProvenHealth Navigator
    Daniel D Maeng
    Geisinger Health System, Danville, PA 17822, USA
    Am J Med Qual 27:210-6. 2012
    ..The results show that, despite its relatively short period of existence, PHN has led to significant improvements in certain outcomes, further illustrating its potential as a care delivery model to be adopted on a wider scale...
  6. ncbi request reprint Reducing long-term cost by transforming primary care: evidence from Geisinger's medical home model
    Daniel D Maeng
    Geisinger Center for Health Research, Danville, PA 17822, USA
    Am J Manag Care 18:149-55. 2012
    ..To estimate cost savings associated with ProvenHealth Navigator (PHN), which is an advanced model of patient-centered medical homes (PCMHs) developed by Geisinger Health System, and determine whether those savings increase over time...
  7. doi request reprint Can health insurance improve employee health outcome and reduce cost? An evaluation of Geisinger's employee health and wellness program
    Daniel D Maeng
    Geisinger Health System Drs Maeng and Steinhubl and Mr Pitcavage and Geisinger Health Plan Ms Tomcavage, Danville, PA
    J Occup Environ Med 55:1271-5. 2013
    ..To evaluate the impact of a health plan-driven employee health and wellness program (known as MyHealth Rewards) on health outcomes (stroke and myocardial infarction) and cost of care...
  8. pmc Cost-effectiveness of IL28Β genotype-guided protease inhibitor triple therapy versus standard of care treatment in patients with hepatitis C genotypes 2 or 3 infection
    Jonathan A Bock
    Weis Center for Research, Geisinger Medical Center, Danville, PA, USA
    Public Health Genomics 17:306-19. 2014
    ..Short- and long-term costs and outcomes of SOC therapy were calculated and used to determine the cost-effectiveness thresholds for using triple therapy in HCV genotype 2 or 3 infected patients...